168 related articles for article (PubMed ID: 9705957)
1. Angiostatin-mediated suppression of cancer metastases by primary neoplasms engineered to produce granulocyte/macrophage colony-stimulating factor.
Dong Z; Yoneda J; Kumar R; Fidler IJ
J Exp Med; 1998 Aug; 188(4):755-63. PubMed ID: 9705957
[TBL] [Abstract][Full Text] [Related]
2. Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma.
Dong Z; Kumar R; Yang X; Fidler IJ
Cell; 1997 Mar; 88(6):801-10. PubMed ID: 9118223
[TBL] [Abstract][Full Text] [Related]
3. GM-CSF-transduced B16 melanoma cells are highly susceptible to lysis by normal murine macrophages and poorly tumorigenic in immune-compromised mice.
Kumar R; Yoneda J; Fidler IJ; Dong Z
J Leukoc Biol; 1999 Jan; 65(1):102-8. PubMed ID: 9886252
[TBL] [Abstract][Full Text] [Related]
4. Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation.
van Elsas A; Hurwitz AA; Allison JP
J Exp Med; 1999 Aug; 190(3):355-66. PubMed ID: 10430624
[TBL] [Abstract][Full Text] [Related]
5. Induction of chemokine secretion and enhancement of contact-dependent macrophage cytotoxicity by engineered expression of granulocyte-macrophage colony-stimulating factor in human colon cancer cells.
Shinohara H; Yano S; Bucana CD; Fidler IJ
J Immunol; 2000 Mar; 164(5):2728-37. PubMed ID: 10679114
[TBL] [Abstract][Full Text] [Related]
6. Mouse macrophage metalloelastase gene transfer into a murine melanoma suppresses primary tumor growth by halting angiogenesis.
Gorrin-Rivas MJ; Arii S; Furutani M; Mizumoto M; Mori A; Hanaki K; Maeda M; Furuyama H; Kondo Y; Imamura M
Clin Cancer Res; 2000 May; 6(5):1647-54. PubMed ID: 10815882
[TBL] [Abstract][Full Text] [Related]
7. Antitumor effects of granulocyte-macrophage colony-stimulating factor production by melanoma cells.
Armstrong CA; Botella R; Galloway TH; Murray N; Kramp JM; Song IS; Ansel JC
Cancer Res; 1996 May; 56(9):2191-8. PubMed ID: 8616871
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of tumor growth correlates with the expression level of a human angiostatin transgene in transfected B16F10 melanoma cells.
Ambs S; Dennis S; Fairman J; Wright M; Papkoff J
Cancer Res; 1999 Nov; 59(22):5773-7. PubMed ID: 10582698
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of murine melanoma growth by granulocyte-macrophage colony stimulating factor gene transfection is not haplotype specific.
Botella R; Sarradet MD; Potter LE; Lawley M; Galloway TH; Ansel JC; Armstrong CA
Melanoma Res; 1998 Jun; 8(3):245-54. PubMed ID: 9664146
[TBL] [Abstract][Full Text] [Related]
10. Effect of serum deprivation on constitutive production of granulocyte-colony stimulating factor and granulocyte macrophage-colony stimulating factor in lung cancer cells.
Uemura Y; Kobayashi M; Nakata H; Harada R; Kubota T; Taguchi H
Int J Cancer; 2004 May; 109(6):826-32. PubMed ID: 15027115
[TBL] [Abstract][Full Text] [Related]
11. Novel membrane-bound GM-CSF vaccines for the treatment of cancer: generation and evaluation of mbGM-CSF mouse B16F10 melanoma cell vaccine.
Yei S; Bartholomew RM; Pezzoli P; Gutierrez A; Gouveia E; Bassett D; Soo Hoo W; Carlo DJ
Gene Ther; 2002 Oct; 9(19):1302-11. PubMed ID: 12224013
[TBL] [Abstract][Full Text] [Related]
12. Paradoxical effect of GM-CSF gene transfer on the tumorigenicity and immunogenicity of murine tumors.
Wang J; Yang WK; Yang Y; Wei SJ; Yang DM; Whang-Peng J; Chen YM; Ting KL; Ting CC
Int J Cancer; 1998 Jan; 75(3):459-66. PubMed ID: 9455809
[TBL] [Abstract][Full Text] [Related]
13. Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cells.
Cao X; Zhang W; Wang J; Zhang M; Huang X; Hamada H; Chen W
Immunology; 1999 Aug; 97(4):616-25. PubMed ID: 10457215
[TBL] [Abstract][Full Text] [Related]
14. Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system.
Sampson JH; Archer GE; Ashley DM; Fuchs HE; Hale LP; Dranoff G; Bigner DD
Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10399-404. PubMed ID: 8816812
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy for metastatic brain tumors by vaccination with granulocyte-macrophage colony-stimulating factor-transduced tumor cells.
Yu JS; Burwick JA; Dranoff G; Breakefield XO
Hum Gene Ther; 1997 Jun; 8(9):1065-72. PubMed ID: 9189764
[TBL] [Abstract][Full Text] [Related]
16. Mouse macrophage metalloelastase generates angiostatin from plasminogen and suppresses tumor angiogenesis in murine colon cancer.
Xu Z; Shi H; Li Q; Mei Q; Bao J; Shen Y; Xu J
Oncol Rep; 2008 Jul; 20(1):81-8. PubMed ID: 18575722
[TBL] [Abstract][Full Text] [Related]
17. MCA106 fibrosarcoma cells transduced with granulocyte/macrophage colony-stimulating factor are not superior to the wild-type cells in suppressing the growth of hepatic metastases.
Dong XD; Abdel-Wahab Z; Dematos P; Fong T; Pruitt SK; Seigler HF
J Surg Oncol; 1999 May; 71(1):36-45. PubMed ID: 10362090
[TBL] [Abstract][Full Text] [Related]
18. Taxol induces the hematopoietic growth factor granulocyte-macrophage colony-stimulating factor in murine B-cells by stabilization of granulocyte-macrophage colony-stimulating factor nuclear RNA.
Pluznik DH; Lee NS; Sawada T
Cancer Res; 1994 Aug; 54(15):4150-4. PubMed ID: 7913412
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 inhibitor NS-398 suppresses cell growth and constitutive production of granulocyte-colony stimulating factor and granulocyte macrophage-colony stimulating factor in lung cancer cells.
Nakata H; Uemura Y; Kobayashi M; Harada R; Taguchi H
Cancer Sci; 2003 Feb; 94(2):173-80. PubMed ID: 12708493
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-inducible factor-2α regulates GM-CSF-derived soluble vascular endothelial growth factor receptor 1 production from macrophages and inhibits tumor growth and angiogenesis.
Roda JM; Sumner LA; Evans R; Phillips GS; Marsh CB; Eubank TD
J Immunol; 2011 Aug; 187(4):1970-6. PubMed ID: 21765015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
